Sanofi 4Q Revenues: $11.0 billion (+9%) 4Q Earnings: $2.7 billion (+13%) FY Revenues: $43.2 billion (+3%) FY Earnings: $11.4 billion (+5%) Comments: In the quarter pharmaceutical sales were $9.3 billion (+11%), which includes the contribution of $1.1 billion from Genzyme, as well as the impact of generic competition to Lovenox (-13%), Ambien CR (-14%), Taxotere (-68%). For the year pharmaceuticals sales were $36.1 billion, up 7%. Vaccines sales were up 7% (excluding A/H1N1 sales) to $4.5 bi...